These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7683881)
1. Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group. Strand V; Lipsky PE; Cannon GW; Calabrese LH; Wiesenhutter C; Cohen SB; Olsen NJ; Lee ML; Lorenz TJ; Nelson B Arthritis Rheum; 1993 May; 36(5):620-30. PubMed ID: 7683881 [TBL] [Abstract][Full Text] [Related]
2. Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function. Fishwild DM; Strand V J Rheumatol; 1994 Apr; 21(4):596-604. PubMed ID: 7518519 [TBL] [Abstract][Full Text] [Related]
3. A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus. Stafford FJ; Fleisher TA; Lee G; Brown M; Strand V; Austin HA; Balow JE; Klippel JH J Rheumatol; 1994 Nov; 21(11):2068-70. PubMed ID: 7532717 [TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group. Olsen NJ; Brooks RH; Cush JJ; Lipsky PE; St Clair EW; Matteson EL; Gold KN; Cannon GW; Jackson CG; McCune WJ; Fox DA; Nelson B; Lorenz T; Strand V Arthritis Rheum; 1996 Jul; 39(7):1102-8. PubMed ID: 8670317 [TBL] [Abstract][Full Text] [Related]
5. Differential patterns of response in patients with rheumatoid arthritis following administration of an anti-CD 5 immunoconjugate. Strand V; Lee ML Clin Exp Rheumatol; 1993; 11 Suppl 8():S161-3. PubMed ID: 7686831 [TBL] [Abstract][Full Text] [Related]
6. Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team. Skyler JS; Lorenz TJ; Schwartz S; Eisenbarth GS; Einhorn D; Palmer JP; Marks JB; Greenbaum C; Saria EA; Byers V J Diabetes Complications; 1993; 7(4):224-32. PubMed ID: 7693056 [TBL] [Abstract][Full Text] [Related]
7. Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate. Cannon GW; Marble DA; Griffiths MM; Cole BC; McCall S; Schulman SF; Strand V J Rheumatol; 1995 Feb; 22(2):207-13. PubMed ID: 7537827 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation. Przepiorka D; LeMaistre CF; Huh YO; Luna M; Saria EA; Brown CT; Champlin RE Ther Immunol; 1994 Apr; 1(2):77-82. PubMed ID: 7584486 [TBL] [Abstract][Full Text] [Related]
9. In vivo T cell depletion in rheumatoid arthritis is associated with increased in vitro IgM-rheumatoid factor synthesis. Olsen NJ; Teal GP; Strand V Clin Immunol Immunopathol; 1993 May; 67(2):124-9. PubMed ID: 7686090 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in vivo. Verwilghen J; Kingsley GH; Ceuppens JL; Panayi GS Arthritis Rheum; 1992 Dec; 35(12):1445-51. PubMed ID: 1282008 [TBL] [Abstract][Full Text] [Related]
11. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Weisdorf D; Filipovich A; McGlave P; Ramsay N; Kersey J; Miller W; Blazar B Bone Marrow Transplant; 1993 Nov; 12(5):531-6. PubMed ID: 8298565 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of an anti-CD5-ricin A chain immunoconjugate in an improved human peripheral blood lymphocyte--reconstituted severe combined immunodeficient mouse model. Kohn FR; Fishwild DM; Kung AH Int J Immunopharmacol; 1993 Aug; 15(6):695-709. PubMed ID: 7691766 [TBL] [Abstract][Full Text] [Related]
13. Effect of gold therapy on CD5+ B-cells and TCR gamma delta+ T-cells in patients with rheumatoid arthritis. Hassan J; Feighery C; Bresnihan B; Whelan A Rheumatol Int; 1991; 11(4-5):175-8. PubMed ID: 1723811 [TBL] [Abstract][Full Text] [Related]
14. Expression and function of CD5 and CD28 in patients with rheumatoid arthritis. Verwilghen J; Corrigall V; Pope RM; Rodrigues R; Panayi GS Immunology; 1993 Sep; 80(1):96-102. PubMed ID: 7503950 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia. Fishwild DM; Aberle S; Bernhard SL; Kung AH Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534 [TBL] [Abstract][Full Text] [Related]
16. Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model. Chignola R; Pasti M; Candiani C; Franceschi A; Anselmi C; Tridente G; Colombatti M Int J Cancer; 1995 May; 61(4):535-41. PubMed ID: 7538979 [TBL] [Abstract][Full Text] [Related]
17. Investigation and prevention of artifactual staining in flow cytometric analyses of whole blood samples from patients treated with H65-RTA, an anti-CD5 monoclonal antibody conjugated to ricin A chain. Fishwild DM; Saria EA J Immunol Methods; 1991 Nov; 144(1):27-34. PubMed ID: 1720441 [TBL] [Abstract][Full Text] [Related]
18. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Willkens RF; Urowitz MB; Stablein DM; McKendry RJ; Berger RG; Box JH; Fiechtner JJ; Fudman EJ; Hudson NP; Marks CR Arthritis Rheum; 1992 Aug; 35(8):849-56. PubMed ID: 1642652 [TBL] [Abstract][Full Text] [Related]
19. Treatment of lupus nephritis with CD5 PLUS, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain. Wacholtz MC; Lipsky PE Arthritis Rheum; 1992 Jul; 35(7):837-9. PubMed ID: 1377918 [No Abstract] [Full Text] [Related]
20. [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study]. Westedt ML; Dijkmans BA; Hermans J Rev Rhum Ed Fr; 1994 Oct; 61(9):591-7. PubMed ID: 7858592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]